Cullinan Therapeutics, Inc. (CGEM) ownership: Top institutional holder: Lynx1 Capital Management LP ($127.37M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Lynx1 Capital Management LP | 8963500.00 | $127.37M | 2026-03-31 |
| MPM BIOIMPACT LLC | 7648268.00 | $108.68M | 2026-03-31 |
| BVF INC/IL | 5750683.00 | $81.72M | 2026-03-31 |
| BlackRock, Inc. | 4449966.00 | $63.23M | 2026-03-31 |
| Kynam Capital Management, LP | 3114132.00 | $44.25M | 2026-03-31 |
| STATE STREET CORP | 2544115.00 | $36.15M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2483034.00 | $35.28M | 2026-03-31 |
| VANGUARD GROUP INC | 3298504.00 | $34.14M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-05-05 | |
| Sell | null | 2026-05-05 |
Back to CGEM overview · CGEM earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.